BofA Global Research cuts Booz Allen Hamilton price objective to $68 from $75
BAH•BofA Global Research cut its price objective for Booz Allen Hamilton to $68 from $75.
Related News

HBM Healthcare Investments invests USD 4.5 million in Lycia Therapeutics IPO
LYCA•

Avista Corporation: BofA Global Research cuts price objective to $34 from $37
AVA•

StandardAero, Inc.: CIBC cuts target price to $35 from $38
SARO•

Flagstar Bank, National Association: JP Morgan cuts target price to $11.50 from $14
FLG•

Terawulf Inc.: Jefferies cuts target price to $15 from $25
WULF•